Search for Clinical Trial Results

Sponsored By

Mesothelioma - 55 Studies Found

Status Study
Completed Study Name: Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed
Condition: Malignant Mesothelioma
Date: 2000-01-28
Interventions: Drug: raltitrexed
Completed Study Name: Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Date: 2007-04-09
Interventions:
  • Drug: bortezomib
  • Drug: cisplatin
Completed Study Name: SU5416 in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Date: 2000-07-05
Interventions: Drug: semaxanib
Completed Study Name: Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
Condition: Malignant Mesothelioma
Date: 2007-07-30
Interventions: Drug: dasatinib 50 mg PO bid
Completed Study Name: PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Condition: Malignant Mesothelioma
Date: 2003-02-05
Interventions: Drug: PTK787/ZK 222584 oral
Completed Study Name: S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
Condition: Malignant Mesothelioma
Date: 1999-11-01
Interventions: Drug: gemcitabine hydrochloride Gemcitabine 1000 mg/m^2 days 1, 8 15 (q 28 days)
Completed Study Name: A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma
Condition: Malignant Mesothelioma
Date: 2012-07-18
Interventions: Drug: Tremelimumab Given IV Other Name: CP-675,206
Completed Study Name: Capecitabine in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Date: 2000-01-21
Interventions: Drug: capecitabine
Terminated Study Name: Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Date: 2001-12-07
Interventions: Drug: trabectedin
Terminated Study Name: The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma
Condition: Malignant Mesothelioma
Date: 2012-07-31
Interventions: Drug: Tremelimumab Tremelimumab is administered as endovenous infusion
Next >>>